Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: In vivo and in vitro studies

Immunology

Volumn 87, Issue 1, 1996, Pages 134-140

  Boehme, M W J ^a   Deng, Y ^a   Raeth, U ^a   Bierhaus, A ^a   Ziegler, R ^a   Stremmel, W ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; PARACETAMOL; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLUENZA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REGIONAL PERFUSION; SARCOMA;

ADULT; ANIMALS; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C3H; NEOPLASMS; NEUTROPHILS; RECOMBINANT PROTEINS; THROMBOMODULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030066667     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. ESMON C.T. & OWEN W.G. (1981) Identification of an endothelial cell cofactor for thrombin-catalysed activation of protein C. Proc Natl Acad Sci USA 78, 2249.
2. ESMON N.L., OWEN W.G. & ESMON C.T. (1982) Isolation of a membrane-hound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257, 859.
3. DITTMAN W.A. & MAJERUS P.W. (1990) Structure and function of thrombomodulin: a natural anticoagulant. Blood 75, 329.
4. ESMON C.T. (1987) The regulation of natural anticoagulant pathways. Science 235, 1348.
5. MARUYAMA I., BELL C.E. & MAJERUS P.W. (1985) Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast on human placenta. J Cell Biol 101, 363.
6. SOFF G.A., JACKMAN R.W. & ROSENBERG R.D. (1991) Expression of thrombomodulin by smooth muscle cells in culture: different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 77, 515.
7. COLLINS C.L., ORDONEZ N.G., SCHAEFER R. et al. (1992) Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 141, 827.
8. TAMURA A., MATSUBARA O., HIROKAWA K. & AOKI N. (1993) Detection of thrombomodulin in human lung cancer cells. Am J Pathol 142, 79.
9. FINK L.M., EIDT J.F., JOHNSON K. et al. (1993) Thrombomodulin activity and localization. Int J Dev Biol 37, 221.
10. SUZUKI K., NISHIOKA J., HAYASHI T. & KOSAKA Y. (1988) Functionally active thrombomodulin is present in human platelets. J Biochem 104, 628.
11. CONWAY F.M., NOWAKOWSKI B. & STEINER-MOSONYI M. (1992) Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 80, 1254.
12. ISHII H. & MAJERUS P.W. (1985) Thrombomodulin is present in human plasma and urine. J Clin Invest 76, 2178.
13. TAKANO S., KIMURA S., OHDAMA S. & AOKI N. (1990) Plasma thrombomodulin in health and diseases. Blood 76, 2024.
14. ISHII H., NAKANO M., TSUBOUCHI J. et al. (1990) Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost 63, 157.
15. KODAMA S., UCIHJIMA E., NAGAI M., MIKAWATANI K., HAYASHI T. & SUZUKI K. (1990) One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chim Acta 192, 191.
16. ISHII H., UCHIYAMA H. & KAZAMA M. (1991) Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 65, 618.
17. NAWROTH P.P. & STERN D.M. (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163, 740.
18. BEVILACQUA M.P., POBER J.S., MAJEAU G.R., FIERS W., COTRAN R.S. & GIMBRONE M.A. (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83, 4533.
19. BAUER K.A., TEN CATE H., BARZEGAR S., SPRIGGS D.R., SHERMAN M.L. & ROSENBERG D.D. (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74, 165.
20. HASHIMOTO Y., HIROHATA S., KASHIWADO R., ITOH K. & ISHII H. (1992) Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells. Inflammation 16, 613.
21. MOORE K.L., ESMON C.T. & ESMON N.L. (1989) Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73, 159.
22. CONWAY E.M., BOFFA M.-C., Nowakowski B. & STEINER-MOSONYI M. (1992) An ultrastructural study of thrombomodulin endocytosis: internalization occurs via clathrin-coated and non-coated pits. J Cell Physiol 151, 604.
23. BRISSON C., ARCHIPOFF G., HARTMANN M.-L. et al. (1992) Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb Haemost 68, 737.
24. HIROKAWA K. & AOKI N. (1991) Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol 147, 157.
25. LENTZ S.R., TSIANG M. & SADLER J.E. (1991) Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and post-transcriptional mechanisms. Blood 77, 542.
26. BOEHME M.W.J., NAWROTH P.P., KLING E. et al. (1994) Serum thrombomodulin: a novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 37, 572.
27. TAKAYA M., ICHIKAWA Y., KOBAYASHI N. et al. (1991) Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 9, 495.
28. KARMOCHKINE M., BOFFA M.C., PIETTE J.C. et al. (1992) Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. Blood 79, 837.
29. BOEHME M.W.J., WERLE E., KOMMERELL B. & RAETH U. (1994) Serum levels of adhesion molecules and thrombomodulin as indicators of vascular injury in severe Plasmodium falciparum malaria. Clin Invest 72, 598.
30. DEGECHI Y., SHIBATA N. & KISHIMOTO S. (1990) Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis. Clin Exp Immunol 81, 311.
31. BOEHME M.W.J., WALDHERR R., KIST A. et al. (1996) Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF-α therapy Eur J Clin Invest (in press).
32. SIDHU R.S. & BOLLON AP. (1993) Tumor necrosis factor activities and cancer therapy a perspective. Pharmacol Ther 57, 79.
33. LIENARD D., EWALENKO P., DELMOTTE J.-J., RENARD N. & LAJEUNE F.J. (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10, 52.
34. JAFFE E.A., NACHMAN R.L., BECKER C.G. & MINICK C.R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52, 2745.
35. NAWROTH P., HANDLEY D., MATSUEDA G. et al. (1988) Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 168, 637.
36. NAWROTH P.P., BANK I., HANDLEY D., CASSIMERIS J., CHESS L. & STERN D. (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163, 1363.
37. NAWROTH P.P., HANDLEY D.A., ESMON C.T. & STERN D.M. (1986) Interleukin-1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83, 3460.
38. CARSWELL E.A., OLD L.J., KASSEL R.L., GREEN S., FIORE N. & WILLIAMSON B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72, 3666.
39. OLD L.J. (1985) Tumor necrosis factor (TNF). Science 230, 630.
40. BEUTLER B. & CERAMI A. (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320, 584.
41. PALLADINO M.A., SHALABY M.R., KRAMER S.M. et al. (1987) Characterization of the antitumor activities of human tumor necrosis factor-α and the comparison with other cytokines: induction of tumor-specific immunity. J Immunol 138, 4023.
42. BEUTLER B. & CERAMI A. (1988) Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem 57, 505.
43. BAGLIONI C. (1992) Mechanisms of cytotoxicity, cytolysis, and growth stimulation by TNF. In: Tumor Necrosis Factor (ed. B. Beutler), pp. 425-438. Raven Press Ltd, New York.
44. POBER J.S. & COTRAN R.S. (1990) Cytokines and endothelial cell biology. Physiol Rev 70, 427.
45. HEMMER C.J., BIERHAUS A., RIEDESEL J. et al. (1994) Elevated thrombomodulin plasma levels as a result of endothelial involvement in Plasmodium falciparum malaria. Thromb Haemost 72, 457.
46. SMEDLY L.A., TONNESEN M.G., SANDHAUS R.A. et al. (1986) Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J Clin Invest 77, 1233.
47. ZECK-KAPP G., KAPP A., BUSSE R. & RIEDE UN. (1990) Interaction of granulocytes and endothelial cells upon stimulation with tumor necrosis factor-α: An ultrastructural study. Immunobiology 181, 267.
48. SACKS T., MOLDOW C.F., CRADDOCK P.R., BOWERS T.K. & JACOB H.S. (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest 61, 1161.
49. YAMADA O., MOLDOW C.F., SACKS T., CRADDOCK P.R., BOOGAERTS M.A. & JACOB H.S. (1981) Deleterious effects of endotoxin on cultured endothelial cells: an in vitro model of vascular injury. Inflammation 5, 115.
50. HARLAN J.M., KILLEN P.D., HARKER L.A., STRIKER G.E. & WRIGHT D.G. (1981) Neutrophil-mediated endothelial injury in vitro: mechanisms of cell detachment. J Clin Invest 68, 1394.
51. WEISS S.J., YOUNG J., LOBUGLIO A.F., SLIVKA A. & NIMEH N.F. (1981) Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest 68, 714.
52. VARANI J., BENDELOW M.J., SEALEY D.L. et al. (1988) Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest 59, 292,
53. VARANI J., GINSBURG I., SCHUGER L. et al. (1989) Endothelial cell killing by neutrophils: synergistic interaction of oxygen products and proteases. Am J Pathol 135, 435.
54. WESTLIN W.F. & GIMBRONE M.A. (1993) Neutrophil-mediated damage to human vascular endothelium: role of cytokine activation. Am J Pathol 142, 117.
55. BEVILAQUA M.P. (1993) Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11, 767.
56. SPRINGER T.A. (1990) Adhesion receptors of the immune system. Nature 346, 425.
57. GAMBLE J.R., SMITH W.B. & VADAS M.A. (1992) TNF modulation of endothelial and neutrophil adhesion. In: Tumor Necrosis Factor (ed. B. Beutler), p. 65. Raven Press Ltd, New York.
58. WANKOWICZ Z., MEGYERI P. & ISSEKUTZ A. (1988) Synergy between tumour necrosis factor α and interleukin-1 in the induction of polymorphonuclear leukocyte migration during inflammation. J Leukoc Biol 43, 349.
59. CARLOS T., KOVACH N., SCHWARTZ B. et al. (1991) Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood 77, 2266.
60. GEARING A.J.H., HEMINGWAY I., PIGOTT R., HUGHES J., REES A.J. & CASHMAN S.J. (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 667, 324.
61. GERLACH H., LIEBERMAN H., BACH R., GODMAN G., BRETT J. & STERN D. (1989) Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med 170, 913.
62. CLAUSS M., MURRAY C., VIANNA V. et al. (1990) A polypeptide factor produced by fibrosarcoma cells that induces endothelial cell tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem 265, 7078.
63. LINDAHL A.K., BOFFA M.-C. & ABILDGAARD U. (1993) Increased plasma thrombomodulin in cancer patients. Thromb Haemost 69, 112.